Application 220366
- Type
- ANDA
- Sponsor
- STERANCO HLTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LACOSAMIDE | LACOSAMIDE | SOLUTION;ORAL | 10MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220366-001 | LACOSAMIDE | LACOSAMIDE | 10MG/ML | SOLUTION / ORAL | 2026-05-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A220366-001 | LACOSAMIDE | 10MG/ML | SOLUTION / ORAL | 2026-05-21 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A220366-001 | LACOSAMIDE | 10MG/ML | SOLUTION / ORAL | 2026-05-21 | caaa826d4ba7… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220366-001 | LACOSAMIDE | 10MG/ML | SOLUTION / ORAL | AA | 2026-05-21 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220366-001 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lacosamide | LACOSAMIDE | Indoco Remedies Limited | ba337b2c-7c1f-4f7b-ba93-054f502400f3 | 2024-03-26 | Warnings, Adverse reactions | Lacosamide LACOSAMIDE |
| Lacosamide | LACOSAMIDE | Alembic Pharmaceuticals Inc. | 07b7b3f2-16a0-4deb-883b-10522676d966 | 2023-11-09 | Warnings, Adverse reactions | Lacosamide LACOSAMIDE |
| LACOSAMIDE | LACOSAMIDE | Zydus Lifesciences Limited | 3bc84c70-bc1d-4a72-bbe7-86f32cd646d0 | 2023-10-03 | LACOSAMIDE LACOSAMIDE | |
| Lacosamide | LACOSAMIDE | Tris Pharma Inc | 7f37f8b8-07d3-48c4-a0c4-7652b62a1ad9 | 2023-06-26 | Warnings, Adverse reactions | Lacosamide LACOSAMIDE |
| Lacosamide | LACOSAMIDE | Alembic Pharmaceuticals Limited | 46b98d5e-fdb6-483a-b022-8b1f0aa832c5 | 2023-01-27 | Warnings, Adverse reactions | Lacosamide LACOSAMIDE |
| LACOSAMIDE | LACOSAMIDE | XLCare Pharmaceuticals Inc. | c7793da3-787b-4364-9192-7caab49066f1 | 2023-01-27 | Warnings, Adverse reactions | LACOSAMIDE LACOSAMIDE |
| lacosamide | LACOSAMIDE | MSN LABORATORIES PRIVATE LIMITED | 0ae4e2d1-305d-4045-95da-cfe7c2d8b435 | 2022-04-21 | lacosamide LACOSAMIDE | |
| Lacosamide | LACOSAMIDE | Indoco Remedies Limited | 145b4fae-ce6d-43e8-a474-fcb9dff92a53 | 2022-03-09 | Warnings, Adverse reactions | Lacosamide LACOSAMIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.